<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A cerebral vasodilatory capacity map, consisting of a 99mTc-<z:chebi fb="0" ids="35739">DTPA</z:chebi>-HSA SPECT image obtained after <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> injection minus the baseline image, was produced in a patient with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The map demonstrated diminished capacity in the posterior region of the right cerebral hemisphere </plain></SENT>
<SENT sid="2" pm="."><plain>Subsequently, <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> occurred in the corresponding area </plain></SENT>
<SENT sid="3" pm="."><plain>This observation suggests that regions of low vasodilatory capacity identified by cerebral vasodilatory capacity mapping may be at high risk of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>